Your browser doesn't support javascript.
loading
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI.
Gupta, Shruti; Garcia-Carro, Clara; Prosek, Jason M; Glezerman, Ilya; Herrmann, Sandra M; Garcia, Pablo; Abudayyeh, Ala; Lumlertgul, Nuttha; Malik, A Bilal; Loew, Sebastian; Beckerman, Pazit; Renaghan, Amanda D; Carlos, Christopher A; Rashidi, Arash; Mithani, Zain; Deshpande, Priya; Rangarajan, Sunil; Shah, Chintan V; Seigneux, Sophie De; Campedel, Luca; Kitchlu, Abhijat; Shin, Daniel Sanghoon; Coppock, Gaia; Ortiz-Melo, David I; Sprangers, Ben; Aggarwal, Vikram; Benesova, Karolina; Wanchoo, Rimda; Murakami, Naoka; Cortazar, Frank B; Reynolds, Kerry L; Sise, Meghan E; Soler, Maria Jose; Leaf, David E.
Affiliation
  • Gupta S; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA sgupta21@bwh.harvard.edu.
  • Garcia-Carro C; Nephrology Department, San Carlos Clinical University Hospital, Madrid, Spain.
  • Prosek JM; Division of Nephrology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Glezerman I; Renal Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA.
  • Herrmann SM; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
  • Garcia P; Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Abudayyeh A; Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lumlertgul N; Department of Critical Care, Guy's and St Thomas' Hospitals NHS Trust, London, UK.
  • Malik AB; Division of Nephrology, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Loew S; Division of Nephrology, University of Washington, Seattle, Washington, USA.
  • Beckerman P; Department of Nephrology and Medical Intensive Care, Charite Universitatsmedizin Berlin, Berlin, Germany.
  • Renaghan AD; Institute of Nephrology and Hypertension, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Carlos CA; Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia, USA.
  • Rashidi A; Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Mithani Z; Division of Nephrology and Hypertension, University Hospital Cleveland Medical Center, Cleveland, Ohio, USA.
  • Deshpande P; University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Rangarajan S; Division of Nephrology, Department of Medicine, Icahn School of Medicine at the Mount Sinai Hospital, New York, NY, USA.
  • Shah CV; Division of Hematology/Oncology and Division of Nephrology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
  • Seigneux S; Division of Nephrology, Hypertension, and Renal Transplant, Department of Medicine, University of Florida, Gainesville, Florida, USA.
  • Campedel L; Service of Nephrology, Department of Medicine, University Hospitals of Geneva, Geneve, Switzerland.
  • Kitchlu A; Department of Medical Oncology, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, Hôpital Pitié-Salpêtrière, Institut universitaire de cancérologie, CLIP Galilée, Groupe de Recherche Interdisciplinaire Francophone en Onco-néphrologie (GRIFON), Paris, France.
  • Shin DS; Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Coppock G; Division of Hematology-Oncology, VAGLAHS, Department of Medicine, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA, USA.
  • Ortiz-Melo DI; Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Sprangers B; Division of Nephrology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Aggarwal V; Department of Microbiology, Immunology and Transplantation, Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Belgium.
  • Benesova K; Division of Nephrology, University Hospitals Leuven, Leuven, Belgium.
  • Wanchoo R; Department of Nephrology and Hypertension, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Murakami N; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Cortazar FB; Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.
  • Reynolds KL; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Sise ME; New York Nephrology Vasculitis and Glomerular Center, Albany, New York, USA.
  • Soler MJ; Division of Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Leaf DE; Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
J Immunother Cancer ; 10(9)2022 09.
Article in En | MEDLINE | ID: mdl-36137651
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Kidney Injury / Immune Checkpoint Inhibitors Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Immunother Cancer Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Kidney Injury / Immune Checkpoint Inhibitors Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Immunother Cancer Year: 2022 Document type: Article Affiliation country: Country of publication: